awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39454030-3C8C978C-4C62-49A5-A7AE-381EDCAC66AF
Q39454030-3C8C978C-4C62-49A5-A7AE-381EDCAC66AF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39454030-3C8C978C-4C62-49A5-A7AE-381EDCAC66AF
Nivolumab for the treatment of bladder cancer.
P2860
Q39454030-3C8C978C-4C62-49A5-A7AE-381EDCAC66AF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39454030-3C8C978C-4C62-49A5-A7AE-381EDCAC66AF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5f27068dc86d70e0df720fab39251187b93e8e30
P2860
Safety and Efficacy of Durvalumab (MEDI4736), an Anti-Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer.